Antioxidants and CVD in diabetes: Where do we stand now?

Current Diabetes Reports

Volumn 7, Issue 1, 2007, Pages 8-13

  Yim, Susie ^a   Malhotra, Atul ^a   Veves, Aristidis ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BENFOTIAMINE; CAFFEINE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; POLYPHENOL DERIVATIVE; TETRAHYDROBIOPTERIN; VITAMIN B GROUP;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COFFEE; DIABETES MELLITUS; DIETARY INTAKE; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; FATTY ACID BLOOD LEVEL; HEART FAILURE; HUMAN; HYPERGLYCEMIA; MEDITERRANEAN DIET; META ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TEA; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIET; ENDOTHELIUM; HUMANS; OXIDATIVE STRESS;

EID: 33847382512     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-007-0003-9     Document Type: Review

References (50)

1. King GL, Loeken MR: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004, 122:333-338.
2. Nishikawa T, Edelstein D, Du XL, et al.: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
3. Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003, 108:1527-1532.
4. Goldin A, Beckman JA, Schmidt AM, Creager MA: Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114:597-605.
5. Hofmann MA, Drury S, Fu C, et al.: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
6. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
7. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 1994, 93:311-320.
8. Kolm-Litty V, Sauer U, Nerlich A, et al.: High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 1998, 101:160-169.
9. Du XL, Edelstein D, Dimmeler S, et al.: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001, 108:1341-1348.
10. Pacher P, Szabo C: Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 2006, 6:136-141.
11. Johansen JS, Harris AK, Rychly DJ, Ergul A: Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005, 4:5.
12. Maritim AC, Sanders RA, Watkins JB 3rd: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
13. Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, et al.: Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb 1994, 14:494-499.
14. Cinar MG, Ulker S, Alper G, Evinc A: Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin-diabetic rats. Pharmacology 2001, 62:56-64.
15. Palmer AM, Thomas CR, Gopaul N, et al.: Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia 1998, 41:148-156.
16. Alper G, Olukman M, Irer S, et al.: Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic rat. Diabetes Metab Res Rev 2006, 22:190-197.
17. Gorbunov NV, Osipov AN, Sweetland MA, et al.: NO-redox paradox: direct oxidation of alpha-tocopherol and alpha-tocopherol-mediated oxidation of ascorbate. Biochem Biophys Res Commun 1996, 219:835-841.
18. Moens AL, Kass DA: Tetrahydrobiopterin and cardio-vascular Disease. Arterioscler Thromb Vasc Biol 2006, 26:2439-2444.
19. Akamine EH, Kawamoto EM, Scavone C, et al.: Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J Vasc Res 2006, 43:309-320.
20. Meininger CJ, Marinos RS, Hatakeyama K, et al.: Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J 2000, 349:353-356.
21. d'Uscio LV, Katusic ZS: Increased vascular biosynthesis of tetrahydrobiopterin in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 2006, 290:H2466-H2471.
22. Hammes HP, Du X, Edelstein D, et al.: Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003, 9:294-299.
23. Marchetti V, Menghini R, Rizza S, et al.: Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 2006, 55:2231-2237.
24. Beckman JA, Goldfine AB, Gordon MB, Creager MA: Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001, 103:1618-1623.
25. Timimi FK, Ting HH, Haley EA, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998, 31:552-557.
26. Ting HH, Timimi FK, Boles KS, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1996, 97:22-28.
27. Schneider MP, Delles C, Schmidt BM, et al.: Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Am J Hypertens 2005, 18:1111-1117.
28. Beckman JA, Goldfine AB, Gordon MB, et al.: Oral antioxidant therapy improves endothelial function in type 1 but not type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2003, 285:H2392-H2398.
29. Chen H, Karne RJ, Hall G, et al.: High-dose oral vitamin C partially replenishes vitamin C levels in patients with type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006, 290:H137-H145.
30. Jackson TS, Xu A, Vita JA, Keaney JF Jr: Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998, 83:916-922.
31. Economides PA, Khaodhiar L, Caselli A, et al.: The effect of vitamin E on endothelial function of micro- and macro-circulation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes 2005, 54:204-211.
32. Stephens NG, Parsons A, Schofield PM, et al.: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347:781-786.
33. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [no authors listed]. Lancet 1999, 354:447-455.
34. Yusuf S, Dagenais G, Pogue J, et al.: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:154-160.
35. Lonn E, Bosch J, Yusuf S, et al.: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338-1347.
36. Eidelman RS, Hollar D, Hebert PR, et al.: Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004, 164:1552-1556.
37. Shekelle PG, Morton SC, Jungvig LK, et al.: Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 2004, 19:380-389.
38. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al.: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
39. Ihlemann N, Rask-Madsen C, Perner A, et al.: Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 2003, 285:H875-H882.
40. Heitzer T, Krohn K, Albers S, Meinertz T: Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 2000, 43:1435-1438.
41. Stirban A, Negrean M, Stratmann B, et al.: Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006, 29:2064-2071.
42. Haupt E, Ledermann H, Kopcke W: Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 2005, 43:71-77.
43. Kushi LH, Folsom AR, Prineas RJ, et al.: Dietary antioxidant vitamins and death from coronary heart disease in post-menopausal women. N Engl J Med 1996, 334:1156-1162.
44. Kris-Etherton P, Eckel RH, Howard BV, et al.: Lyon Diet Heart Study: benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association step I dietary pattern on cardiovascular disease. Circulation 2001, 103:1823-1825.
45. Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, et al.: International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 2005, 35:421-424.
46. Esposito K, Marfella R, Ciotola M, et al.: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
47. van Dam RM, Hu FB: Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005, 294:97-104.
48. Pereira MA, Parker ED, Folsom AR: Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006, 166:1311-1316.
49. Kuriyama S, Shimazu T, Ohmori K, et al.: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006, 296:1255-1265.
50. Iso H, Date C, Wakai K, et al.: The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006, 144:554-562.